Anonymous
(ID: rGzMnzLg)
7/18/2025, 3:22:47 AM
No.60647591
[Report]
>>60647649
>>60647663
>>60647701
ESPR
Esperion Therapeutics, maker of nexlizet and nexletol, the only statin alternatives in the market will receive a buyout offer for $10 Billion from a previously-established partnership between pharmaceutical giants Merck and Daiichi Sankyo